Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Bioadaptives (BDPT) Profit After Tax (2016 - 2025)

Bioadaptives' Profit After Tax history spans 7 years, with the latest figure at -$823346.0 for Q4 2025.

  • On a quarterly basis, Profit After Tax fell 121.46% to -$823346.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$1.6 million, a 73.26% decrease, with the full-year FY2025 number at -$1.6 million, down 73.26% from a year prior.
  • Profit After Tax hit -$823346.0 in Q4 2025 for Bioadaptives, down from -$379502.0 in the prior quarter.
  • Over the last five years, Profit After Tax for BDPT hit a ceiling of -$13061.0 in Q3 2023 and a floor of -$823346.0 in Q4 2025.
  • Historically, Profit After Tax has averaged -$255752.2 across 5 years, with a median of -$246069.0 in 2022.
  • Biggest five-year swings in Profit After Tax: surged 95.27% in 2023 and later plummeted 908.0% in 2025.
  • Tracing BDPT's Profit After Tax over 5 years: stood at -$214283.0 in 2021, then soared by 86.8% to -$28277.0 in 2022, then plummeted by 848.83% to -$268301.0 in 2023, then plummeted by 38.57% to -$371788.0 in 2024, then tumbled by 121.46% to -$823346.0 in 2025.
  • Business Quant data shows Profit After Tax for BDPT at -$823346.0 in Q4 2025, -$379502.0 in Q3 2025, and -$157914.0 in Q2 2025.